Checking a Structured Report for Staging Cervical Cancer
Tests a standard report form to help doctors stage cervical cancer consistently.
Plain-language title generated from the registry record
Registry title: Multidisciplinary Assesssment of Structured Report for Cervical Cancer Staging
Key facts
- Where
- Rome, ItalySee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adult women with cervical cancer confirmed by biopsy, at any stage. It tests a structured report for staging.
- Age
- 18 years or older
- Sex
- Women only
- Disease stage
- Cervical cancer confirmed by biopsy, at any stage
Main reasons for not taking part
- Under 18 years old
- Uncertain diagnosis of cervical cancer
- MRI scan not done according to the standard protocol (ESUR guidelines)
- Candidate for non-standard treatments
- Refusal to sign the written consent for use of personal data for research
Read by machine on 12 November 2026.
Where in Italy
- Advanced Radiology CenterRome, ItalyContact: Luca RussoTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- Trial code
- NCT06260358
- Record updated
- 13 March 2025
- Original description
This study aims to validate a structured report for cervical cancer anchored to the FIGO staging system. A structured report is hypothesized to aid in uniformly applying FIGO staging, reducing staging discrepancies and improving patient care and outcomes.Read full original descriptionShow less
Multidisciplinary Assesssment of Structured Report for Cervical Cancer Staging
This study aims to validate a structured report for cervical cancer anchored to the FIGO staging system. A structured report is hypothesized to aid in uniformly applying FIGO staging, reducing staging discrepancies and improving patient care and outcomes.
Furthermore, we believe that the participation of the clinicians will improve the quality of the report to minimize the need for multidisciplinary team discussion
Inclusion: Age ≥18 years old; Overt biopsy-proven diagnosis of cervical cancer, at any stage; Signed written informed consent to personal data treatment for research purposes.
Exclusion: Uncertain diagnosis of cervical cancer; Age <18 years old; MRI scan not according the standard acquisition protocol (ESUR guidelines); Patients candidate to non-standard treatments; Refusal to sign the written informed consent to personal data treatment for research purposes.